However, the 2024 ECTRIMS presentation describing proposed changes to MS diagnostic criteria identified recommendations for MOG IgG testing in children under the age of 12 presenting with new CNS demyelination, and in children older than 12 years of age with atypical presentations [41]. The gene discussed is MOG; the disease is CNS demyelination.